DeepPSMA

Comprehensive Tumor Analysis

Fast and reproducible whole-body tumor burden quantification in PSMA-PET/CT imaging, delivering critical insights on tumor characteristics.

Accurate Detection

Automatic identification of tumor lesions.

Cancer Staging

Automatic localization of lesions by  TNM classification.

Tumor Quantification

Precise calculation of whole-body tumor burden metrics.
DeepPSMA Report showing whole-body tumor burden analysis, including SUV metrics, tumor volume, number of lesions, and miTNM staging for prostate cancer patients, provided by Nucs AI.

Advanced Tumor Analysis Using PSMA-PET/CT Images

DeepPSMA utilizes AI-technology to enable fast and reliable detection, staging, and quantification of prostate cancer using PSMA-PET/CT images.

Clinical Value

Calculates TNM stage and generates quantitative tumor burden metrics for biomarker analysis and personalized treatment planning.

Benefits

Enables evidence-based clinical management and standardization of PSMA-PET/CT reports.

Applications of DeepPSMA

Discover how DeepPSMA enhances prostate cancer care across various settings.

Clinical Diagnostics

Provides accurate tumor detection and automatic staging of prostate cancer.

Treatment Planning

Enables personalized treatment plans based on advanced tumor analysis of individual patients.

Treatment Monitoring

Enables accurate treatment response evaluation during prostate cancer therapies.

Biomarker Research

Supports clinical research with reliable, reproducible tumor burden quantitative metrics.

Radiology Reports

Enables standardization of PSMA-PET/CT reports.

Contact us today

Take the next step to discover how Nucs AI can transform your clinical management of prostate cancer care.